8-K: ATI Physical Therapy Amends Credit and Note Purchase Agreements

ATI Physical Therapy has amended its credit agreement and note purchase agreement, allowing for the issuance of new debt and a tender offer for its common stock.

Summary

• ATI Physical Therapy has entered into an amendment to its existing credit agreement and note purchase agreement.
• The amendment to the credit agreement allows for certain changes related to the issuance of new debt.
• The amendment to the note purchase agreement allows for the issuance of up to $6 million in new second lien PIK notes.
• The new notes will mature on August 24, 2028, and bear interest at 12% for the first 180 days, then 17% thereafter, payable in kind.
• The proceeds from the new notes will be used to repurchase up to 1,650,000 shares of the company's common stock through a tender offer.
• The company has also amended its Series A Preferred Stock Certificate of Designation to allow for the tender offer.
• The company's common stock was delisted from the NYSE on December 3, 2024, and now trades on the OTC Pink Sheets.

Sentiment

Score: 3

Explanation: The document contains several negative developments, including the delisting from the NYSE and the increase in debt. The tender offer is a positive, but it is not enough to offset the negative news.

Positives

• The amendment to the credit agreement provides flexibility for the company.
• The tender offer may provide some value to shareholders.

Negatives

• The company's common stock was delisted from the NYSE, which is a negative development.
• The new debt will increase the company's leverage.

Risks

• The company's liquidity position raises substantial doubt about its ability to continue as a going concern.
• The company's ability to meet financial covenants as required by its Credit Agreement is uncertain.
• The company faces risks related to outstanding indebtedness and preferred stock, rising interest rates and potential increases in borrowing costs.
• The company's ability to access additional financing or alternative options when needed is uncertain.
• The company is dependent upon governmental and third-party private payors for reimbursement, and changes in reimbursement rates could adversely affect the company's financial results.
• The company faces competition in a rapidly changing industry.
• The company's operations are subject to extensive regulation and macroeconomic uncertainty.
• The company's ability to maintain effective internal control over financial reporting is uncertain.
• The company faces risks related to dilution of Common Stock ownership interests and voting interests as a result of the issuance of 2L Notes and Series B Preferred Stock.
• The company faces costs related to operating as a public company.
• The company faces the impact of the delisting of the Common Stock from the NYSE.

Future Outlook

The company will use the proceeds from the new notes to repurchase up to 1,650,000 shares of its common stock through a tender offer.

Industry Context

The document reflects the company's ongoing efforts to manage its debt and capital structure in a challenging economic environment. The delisting from the NYSE and the move to the OTC Pink Sheets may indicate financial difficulties.

Comparison to Industry Standards

• The company's financial situation appears to be weaker than many of its peers, as evidenced by the delisting from the NYSE and the need to raise additional debt.
• The company's debt levels are high, which is a concern for investors.
• The company's ability to generate positive cash flow and meet its financial obligations is uncertain.

Corporate Governance

Stakeholder Impact

• Shareholders may be concerned about the delisting from the NYSE and the increase in debt.
• Creditors may be concerned about the company's ability to repay its debt.
• Employees may be concerned about the company's financial stability.

Next Steps

• The company will conduct a tender offer for its common stock.
• The company will continue to manage its debt and capital structure.

Key Dates

Keywords

credit agreement, note purchase agreement, second lien PIK notes, tender offer, common stock, delisting, OTC Pink Sheets, debt, capital raise, financial covenants